

Toutes les ressources et actualités à portée de main
Le processus de découverte et de développement d’une molécule est complexe, long et couteux. Avant de prendre une décision sur l’offre qui répond au mieux à votre besoin, nous vous proposons des ressources scientifiques (posters, publications, webinaires) en ligne, nos dernières actualités (congrès, communiqués de presse) pour mieux nous connaitre et nous rencontrer. Nos experts sont également à votre disposition pour vous aider et vous accompagner dans votre programme de recherche et développement.
- Tous
- Congress
- Blog
- Congrès
- Ressource Scientifique
- Webinaire
- Poster
- Publication scientifique
- Communiqué de Presse
- Couverture presse
- Actualités

Webinar – Hidden Potential: Using Fragments to Uncover New Ligandable Sites on Popular Targets
Learn how fragments reveal novel opportunities in well-known drug targets. Watch the webinar to explore strategies, case studies, and actionable insights.

White Paper: Discovering & Advancing Molecular Glues Using a Cooperativity-Based Approach
Discover how a cooperativity-driven approach accelerates molecular glue discovery. Download the white paper to learn more about the science and strategy.
PDX Research Model Guide
Explore 200+ PDX models across 14 cancer types. Better predict clinical response with fully characterized, customizable models. Download now.

Oncodesign Services appoints Aidan Synnott as CEO to enhance strategic drug discovery partnerships
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery.

Publication: The Nature of Nanodisc Lipids Influences Fragment-Based Drug Discovery Results
Discover how nanodisc lipids impact fragment-based drug discovery, enhancing membrane protein screening and enabling new therapeutic possibilities.

Cooperativity: The Missing Link in Molecular Glue Discovery
In this Q&A, discover how cooperativity is unlocking new potential in molecular glues and enabling the targeting of previously “undruggable” proteins.

Case study: Capturing out-of-range target engagement kinetics for an advanceable clinical candidate
Characterizing the inhibition of PRMT5:MTA by MRTX1719, a clinical stage MTAP-deleted cancer therapeutic.

Medicinal Chemist’s Insights into the Microbiome
Here, we highlight the need to consider early the microbiome in drug discovery, as it may influence drug responses, therefor efficacy

Oncology CRO of the year 2024 – FRANCE
Oncodesign Services is thrilled to announce that we have been awarded "Oncology CRO of the year 2024 – France"!

The Game-Changing Role of Artificial Intelligence in Drug Discovery
Discover in this blog how Artificial Intelligence (AI) has a game-changing role in drug discovery and computational chemistry

Radionucléides : un défi d’approvisionnement
Dans ce blog, nous verrons comment surmonter les défis d'approvisionnement en radionucléides avec des solutions innovantes par Oncodesign Services